▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / YBGJ

YBGJ — Yubo International Biotech Ltd

—
OTC · Health Care · Health Care Equipment & Supplies · CIK 895464 ·
Last close
$0.01
Market Cap
$1.19M
52W High
$0.02
52W Low
$0.01
ADV30
3,000
Next earnings
—
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound drink/beverage; and facial care, eye care, and hair care series products. Yubo International Biotech Limited is headquartered in Beijing, China.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 0 0 -289,274 -272,608 709,872 10,382 3,019,451
Dec 2025 12,353 8,165 -285,468 -261,418 847,094 8,062 2,791,296
Sep 2025 0 0 -310,134 -276,771 953,211 10,926 2,555,316
Jun 2025 0 0 -249,699 -230,333 1,051,568 10,416 5,033,282

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-657,915
Investing CF
$6,186
Financing CF
$786,288
CapEx
$-6,186
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-8,012,667
Inventory
$24,414
Receivables
$426,831
ST Investments
—
EBIT TTM
$-1,134,575
Pretax Income TTM
$-1,140,551
Interest Exp TTM
$5,812
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,353
EBITDA
$-847,450
Free Cash Flow
$-238,039
Enterprise Value
$2,637,949
Total Cash
$10,382
Total Debt
$1,467,350
Shares Out
170,416,343
Trailing EPS
$-0.01
Book Value
$-0.01
ROE
—
ROA
-67.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 12,353 -1,187,696 -1,079,248 847,094 2,791,296 — -842,802
Dec 2024 3,470 -1,769,919 -1,775,303 1,534,831 4,832,522 — -1,337,729
Dec 2023 604,676 -1,194,706 -1,195,083 1,667,269 3,510,972 — -738,971
Dec 2022 104,283 -1,205,223 -1,204,994 2,348,551 2,913,924 — -600,953
Dec 2021 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
PFSA Profusa, Inc. $1.18M $0.25 —
LYRA Lyra Therapeutics, Inc. $1.22M $0.69 —
ODYY Odyssey Health, Inc. $1.08M $0.01 —
PREM Premier Air Charter Holdings Inc. $1.45M $0.04 —
ESMC ESCALON MEDICAL CORP $1.48M $0.20 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →